Roque Arteaga
Clinical Cardiac Electrophysiology · Sioux City, IANPI 1164545505
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (50.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Medtronic at 40.9% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in IA, where the typical reported total is $15,103.
Across 279 payments — averaging $54.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Abbott$3K
- Biosense Webster, Inc.$2K
- Medical Device Business Services, Inc.$2K
- Johnson & Johnson$451
- Pfizer$339
- plus $2K from 21 others
What the payments were for
- Travel & lodging$7,58350%
- Food & beverage$7,50550%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 81 | $6,180 |
| Abbott | 31 | $2,653 |
| Biosense Webster, Inc. | 47 | $2,347 |
| Medical Device Business Services, Inc. | 4 | $1,574 |
| Johnson & Johnson | 14 | $451 |
| Pfizer | 24 | $339 |
| Boehringer Ingelheim | 17 | $290 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 18 | $208 |
| E.r. Squibb & Sons, L.L.C. | 12 | $181 |
| Impulse Dynamics (USA) Inc. | 1 | $115 |
| Boston Scientific | 4 | $98 |
| Bayer | 1 | $97 |
| Amgen | 5 | $92 |
| Lantheus Medical Imaging, Inc. | 1 | $91 |
| Inari Medical, Inc. | 1 | $80 |
| Novartis | 5 | $72 |
| Cardiva Medical, Inc. | 1 | $33 |
| Irhythm Technologies, Inc. | 2 | $32 |
| Abiomed | 1 | $29 |
| AstraZeneca | 2 | $26 |
| Lexicon Pharmaceuticals, Inc. | 1 | $21 |
| Catheter Precision Inc. | 1 | $20 |
| Scpharmaceuticals Inc. | 1 | $18 |
| Cardiovascular Systems Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$2,620
- Cardiac Mapping System$846
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$779
- EnSite Precision Cardiac Mapping System$397
- ARCTIC FRONT ADVANCE$287
- Confirm Rx$265
- OPTIMIZER$231
- AMPLATZER$144
- Allure Quadra RF CRT Pacemaker$142
- XARELTO$111
- Micra$106
- AFFERA MAPPING SYSTEM$105
- Assurity Pacemaker$104
- NUVISION ICE CATHETER$102
How this compares
$15,103 in reported general payments places this provider in the 50th percentile of 42 clinical cardiac electrophysiology providers in Iowa.
See all clinical cardiac electrophysiology providers in Iowa →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 878 | $655,964 |
| XareltoRivaroxaban | 497 | $350,456 |
| EntrestoSacubitril/Valsartan | 79 | $54,016 |
| FarxigaDapagliflozin Propanediol | 39 | $27,911 |
| SotalolSotalol Hcl | 891 | $9,314 |
| Praluent PenAlirocumab | 13 | $5,873 |
| Metoprolol Succinate | 505 | $5,175 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 245 | $3,825 |
| Dofetilide | 18 | $3,697 |
| Amiodarone Hcl | 363 | $3,012 |
| Propafenone Hcl | 64 | $2,986 |
| Flecainide Acetate | 55 | $2,643 |
| Propafenone Hcl ErPropafenone Hcl | 22 | $2,611 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 12 | $2,017 |
| Mexiletine Hcl | 27 | $1,534 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $339 | $655,964878 claims |
| Johnson & JohnsonXarelto | $451 | $350,456497 claims |
| NovartisEntresto | $72 | $54,01679 claims |
| AstraZenecaFarxiga | $26 | $27,91139 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 42 clinical cardiac electrophysiology providers in Iowa.
Other clinical cardiac electrophysiology in Sioux City
- Thong PhamSioux City$3K
- Steven MickelsenIowa City$2.4M
- Jason MeyersWest Des Moines$189K
- Mohit ChawlaCedar Rapids$101K
- Paari DominicIowa City$83K
- Nilarun ChowdhuriDavenport$73K
- Peter FarjoIowa City$72K
- Oluwaseun AdeolaIowa City$49K
- Victor AbrichWaterloo$47K
- Steven BailinWest Des Moines$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.